Kevin Hammon

Kevin Hammon is a Vice President in the EQT Life Sciences Team. Kevin joined EQT Life Sciences as an Associate in July 2022. Prior to joining EQT, Kevin worked at BioMarin in R&D within Translational Sciences, where he was involved in the development of several therapies. Prior to BioMarin, Kevin worked in Amgen's Clinical Pharmacology Modelling and Simulation group. Kevin holds a B.S. in Pharmacology from the University of California, Santa Barbara, and an MBA from INSEAD.